Another successful FDA inspection at Alpex Pharma SA

On May 2017 Alpex Pharma has successfully passed a GMP inspection by US FDA and the outcome once more was satisfactory....

Read more

Sustained release

Sustained Release Technology Overview

Sustained release

Oral dosage form;
Hydrophilic-Hydrophobic matrix approach;
Incorporation of up to 600 mg of API on 1500 mg embossed tablet possible;
Duration of release up to 24 hours;